During the COVID-19 pandemic, researchers made a remarkable discovery using artificial intelligence to scan existing FDA-approved medications: the AI identified zafirlukast, a common asthma medication, as a potential dual-action treatment for Covid.
A trend is graded on whether the publisher keeps it, never as a hit or a miss (D6, D33).